Predictors of response for elagolix with add-back therapy in women with heavy menstrual bleeding associated with uterine fibroids is a research paper published in American Journal of Obstetrics and Gynecology (2020). On theSindex it has a DataRank of 1.2. It has been cited 31 times, with 23 citing works in its 1-hop citation network.
Scored on demand from live citation data
Repositories this paper deposited data in (declared in PubMed).
DataRank reads this dataset's downstream impact straight off the citation graph — no black box, no proprietary weighting. How is this computed?
FAIR checklist signals are shown for context only and do not affect DataRank scoring.
We only score data papers we can read in full — never from an abstract alone.
Base Score Contribution
0.520
From this paper's citation signal
Citation Network Contribution
0.684
From 19 citing papers with measurable signal
Ranked by each citer's contribution to N(p) — log1p(Cq) divided by its reference count — out of 23 citers.
National Institutes of Health
Grant: 9,790,562 B2
National Institutes of Health
Grant: R01 ES 028615-01
National Institutes of Health
Grant: R01 HD 087417
National Institutes of Health
Grant: R01 HD 094378
National Institutes of Health
Grant: R01 HD 094380
New England Research Institutes
Grant: P50HS023418
New England Research Institutes
Grant: R01HD 60503
National Institutes of Health
Grant: 1R01ES028615-01
Gene X Environment Interactions in the Pathogenesis of Uterine Fibroids
National Institutes of Health
Grant: 3R01HD094378-02S1
Hypovitaminosis D promotes MED12-associated genomic instability in uterine fibroids
Allergan
Grant: unidentified
unidentified
National Institutes of Health
Grant: 5P50HS023418-04
COMPARE-UF
National Institutes of Health
Grant: 5R01HD060503-05
The FIRSTT Trial: Assessing Outcomes of Minimally Invasive Leiomyoma Therapies
Fields of Study
Keywords
Sustainable Development Goals